Table of Contents

1 Market Overview

• 1.1 Objectives of Research
  • 1.1.1 Definition
  • 1.1.2 Specifications
• 1.2 Market Segment
  • 1.2.1 by Type
    • 1.2.1.1 Non-Steroidal Anti-Inflammatory Drugs (Nsaids)
    • 1.2.1.2 Hormonal
    • 1.2.1.3 Combined Oral Contraceptive
  • 1.2.2 by Application
    • 1.2.2.1 Hospitals
    • 1.2.2.2 Clinics
    • 1.2.2.3 Diagnostic Centers
    • 1.2.2.4 Pharmaceutical Companies
    • 1.2.2.5 Others
  • 1.2.3 by Regions

2 Industry Chain

• 2.1 Industry Chain Structure
• 2.2 Upstream
• 2.3 Market
  • 2.3.1 SWOT
  • 2.3.2 Dynamics

3 Environmental Analysis

• 3.1 Policy
• 3.2 Economic
• 3.3 Technology
• 3.4 Market Entry

4 Market Segmentation by Type

• 4.1 Market Size
  • 4.1.1 Non-Steroidal Anti-Inflammatory Drugs (Nsaids) Market, 2013-2018
  • 4.1.2 Hormonal Market, 2013-2018
  • 4.1.3 Combined Oral Contraceptive Market, 2013-2018
• 4.2 Market Forecast
  • 4.2.1 Non-Steroidal Anti-Inflammatory Drugs (Nsaids) Market Forecast, 2019-2024
  • 4.2.2 Hormonal Market Forecast, 2019-2024
  • 4.2.3 Combined Oral Contraceptive Market Forecast, 2019-2024

5 Market Segmentation by Application

• 5.1 Market Size
  • 5.1.1 Hospitals Market, 2013-2018
  • 5.1.2 Clinics Market, 2013-2018
  • 5.1.3 Diagnostic Centers Market, 2013-2018
  • 5.1.4 Pharmaceutical Companies Market, 2013-2018
  • 5.1.5 Others Market, 2013-2018
• 5.2 Market Forecast
  • 5.2.1 Hospitals Market Forecast, 2019-2024
  • 5.2.2 Clinics Market Forecast, 2019-2024
  • 5.2.3 Diagnostic Centers Market Forecast, 2019-2024
  • 5.2.4 Pharmaceutical Companies Market Forecast, 2019-2024
  • 5.2.5 Others Market Forecast, 2019-2024

6 Market Segmentation by Region

• 6.1 Market Size
  • 6.1.1 Asia-Pacific
    • 6.1.1.1 Asia-Pacific Market, 2012-2018
    • 6.1.1.2 Asia-Pacific Market by Type
    • 6.1.1.3 Asia-Pacific Market by Application
  • 6.1.2 North America
    • 6.1.2.1 North America Market, 2012-2018
    • 6.1.2.2 North America Market by Type
    • 6.1.2.3 North America Market by Application
  • 6.1.3 Europe
    • 6.1.3.1 Europe Market, 2012-2018
    • 6.1.3.2 Europe Market by Type
    • 6.1.3.3 Europe Market by Application
  • 6.1.4 South America
    • 6.1.4.1 South America Market, 2012-2018
    • 6.1.4.2 South America Market by Type
    • 6.1.4.3 South America Market by Application
  • 6.1.5 Middle East & Africa
    • 6.1.5.1 Middle East & Africa Market, 2012-2018
    • 6.1.5.2 Middle East & Africa Market by Type
    • 6.1.5.3 Middle East & Africa Market by Application
• 6.2 Market Forecast
  • 6.2.1 Asia-Pacific Market Forecast, 2019-2024
  • 6.2.2 North America Market Forecast, 2019-2024
  • 6.2.3 Europe Market Forecast, 2019-2024
  • 6.2.4 South America Market Forecast, 2019-2024
  • 6.2.5 Middle East & Africa Market Forecast, 2019-2024

7 Market Competitive

• 7.1 Global Market by Vendors
• 7.2 Market Concentration
• 7.3 Price & Factors
• 7.4 Marketing Channel

8 Major Vendors

• 8.1 Novartis AG (Switzerland)
• 8.2 Merck (U.S)
• 8.3 Bayer Schering Pharma AG (Germany)
• 8.4 Abbott Healthcare (U.S)
• 8.5 Pfizer (U.S)
• 8.6 F. Hoffmann-La Roche Ltd (U.S)
• 8.7 Sanofi (U.S)
• 8.8 Taj Pharmaceuticals (India)

9 Conclusion

Summary
The global Dysmenorrhea Treatment market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Non-Steroidal Anti-Inflammatory Drugs (Nsaids)
Hormonal
Combined Oral Contraceptive
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Novartis AG (Switzerland)
Merck (U.S)
Bayer Schering Pharma AG (Germany)
Abbott Healthcare (U.S)
Pfizer (U.S)
F. Hoffmann-La Roche Ltd (U.S)
Sanofi (U.S)
Taj Pharmaceuticals (India)
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Hospitals
Clinics
Diagnostic Centers
Pharmaceutical Companies
Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa